chr22-31344924-G-A
Position:
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_014323.3(PATZ1):c.679C>T(p.Pro227Ser) variant causes a missense change. The variant allele was found at a frequency of 0.00000411 in 1,461,234 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: not found (cov: 33)
Exomes 𝑓: 0.0000041 ( 0 hom. )
Consequence
PATZ1
NM_014323.3 missense
NM_014323.3 missense
Scores
3
16
Clinical Significance
Conservation
PhyloP100: 4.49
Genes affected
PATZ1 (HGNC:13071): (POZ/BTB and AT hook containing zinc finger 1) The protein encoded by this gene contains an A-T hook DNA binding motif which usually binds to other DNA binding structures to play an important role in chromatin modeling and transcription regulation. Its Poz domain is thought to function as a site for protein-protein interaction and is required for transcriptional repression, and the zinc-fingers comprise the DNA binding domain. Since the encoded protein has typical features of a transcription factor, it is postulated to be a repressor of gene expression. In small round cell sarcoma, this gene is fused to EWS by a small inversion of 22q, then the hybrid is thought to be translocated (t(1;22)(p36.1;q12). The rearrangement of chromosome 22 involves intron 8 of EWS and exon 1 of this gene creating a chimeric sequence containing the transactivation domain of EWS fused to zinc finger domain of this protein. This is a distinct example of an intra-chromosomal rearrangement of chromosome 22. Four alternatively spliced transcript variants are described for this gene. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -6 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.09804198).
BS2
High AC in GnomAdExome4 at 6 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PATZ1 | NM_014323.3 | c.679C>T | p.Pro227Ser | missense_variant | 1/5 | ENST00000266269.10 | |
PATZ1 | NM_032050.2 | c.679C>T | p.Pro227Ser | missense_variant | 1/4 | ||
PATZ1 | NM_032051.2 | c.679C>T | p.Pro227Ser | missense_variant | 1/3 | ||
PATZ1 | NM_032052.2 | c.679C>T | p.Pro227Ser | missense_variant | 1/5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PATZ1 | ENST00000266269.10 | c.679C>T | p.Pro227Ser | missense_variant | 1/5 | 1 | NM_014323.3 | P1 | |
PATZ1 | ENST00000351933.8 | c.679C>T | p.Pro227Ser | missense_variant | 1/4 | 1 | |||
PATZ1 | ENST00000215919.3 | c.679C>T | p.Pro227Ser | missense_variant | 1/3 | 1 | |||
PATZ1 | ENST00000405309.7 | c.679C>T | p.Pro227Ser | missense_variant | 1/5 | 1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 genomes
Cov.:
33
GnomAD3 exomes AF: 0.0000120 AC: 3AN: 249820Hom.: 0 AF XY: 0.00000738 AC XY: 1AN XY: 135418
GnomAD3 exomes
AF:
AC:
3
AN:
249820
Hom.:
AF XY:
AC XY:
1
AN XY:
135418
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000411 AC: 6AN: 1461234Hom.: 0 Cov.: 32 AF XY: 0.00000138 AC XY: 1AN XY: 726922
GnomAD4 exome
AF:
AC:
6
AN:
1461234
Hom.:
Cov.:
32
AF XY:
AC XY:
1
AN XY:
726922
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 33
GnomAD4 genome
Cov.:
33
Bravo
AF:
ExAC
AF:
AC:
1
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 11, 2023 | The c.679C>T (p.P227S) alteration is located in exon 1 (coding exon 1) of the PATZ1 gene. This alteration results from a C to T substitution at nucleotide position 679, causing the proline (P) at amino acid position 227 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
T;.;.;.
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
D
LIST_S2
Uncertain
D;D;D;D
M_CAP
Benign
T
MetaRNN
Benign
T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
L;L;L;L
MutationTaster
Benign
D;D;D;D
PrimateAI
Uncertain
T
PROVEAN
Benign
N;N;N;N
REVEL
Benign
Sift
Benign
D;T;T;T
Sift4G
Benign
T;T;T;T
Polyphen
D;P;B;B
Vest4
MutPred
Loss of catalytic residue at P227 (P = 0.032);Loss of catalytic residue at P227 (P = 0.032);Loss of catalytic residue at P227 (P = 0.032);Loss of catalytic residue at P227 (P = 0.032);
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at